Jun 2 |
Roivant Sciences: Executing On Huge Buyback Program With More To Come
|
May 30 |
Roivant Sciences Ltd. (ROIV) Q4 2023 Earnings Call Transcript
|
May 30 |
Roivant Sciences GAAP EPS of -$0.19 beats by $0.11, revenue of $28.93M misses by $2.01M
|
May 30 |
Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provides Business Update
|
May 29 |
Roivant Sciences Q4 2024 Earnings Preview
|
May 22 |
Vivek Ramaswamy Breathes New Life In Beaten Down BuzzFeed Stock: What's Going On?
|
May 16 |
Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provide Business Update on Thursday, May 30, 2024
|
May 5 |
Institutional investors are Roivant Sciences Ltd.'s (NASDAQ:ROIV) biggest bettors and were rewarded after last week's US$290m market cap gain
|
Apr 24 |
Roivant Sciences: Cashing In On Vants And Ventures
|
Apr 2 |
Roivant announces $1.5B share buyback, positive Phase 2 data
|